Evidence map›Paper›PMID 31625857›Full record

ArticleEmerging infectious diseases2019

Availability of Injectable Antimicrobial Drugs for Gonorrhea and Syphilis, United States, 2016.

William S Pearson, Donald K Cherry, Jami S Leichliter, Laura H Bachmann, Nicole A Cummings, Matthew Hogben

Open access · diamondAbstract readHistorical ArticleLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Emerging infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 5 countries.

William S Pearson
Donald K Cherry
Jami S Leichliter
Laura H Bachmann
Nicole A Cummings
Matthew Hogben
Czech Academy of Sciences, Biology Centre · CZHyattsville Community Development Corporation · USCenters for Disease Control and Prevention · USCentre de Recerca en Sanitat Animal · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We estimated the availability of the injectable antimicrobial drugs recommended for point-of-care treatment of gonorrhea and syphilis among US physicians who evaluated patients with sexually transmitted infections in 2016. Most physicians did not have these drugs available on-site. Further research is needed to determine the reasons for the unavailability of these drugs.

Indexed as

Health Services AccessibilityAnti-Infective AgentsGonorrheaHistory, 21st CenturyHumansSexually Transmitted DiseasesSyphilisUnited StatesAnti-Infective Agentsaccess to careantibioticantimicrobial drugsbacteriaceftriaxonedrug availabilitygonorrheainjectable antimicrobial drugsNeisseria gonorrheoaepatient-centered medical homespenicillin G benzathinesexually transmitted infectionsSTIssyphilisTreponema pallidumUnited States

Identifiers

PMID31625857
PMCPMC6810217
OpenAlexW2979499229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.